NO862372D0 - Fremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater. - Google Patents

Fremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater.

Info

Publication number
NO862372D0
NO862372D0 NO862372A NO862372A NO862372D0 NO 862372 D0 NO862372 D0 NO 862372D0 NO 862372 A NO862372 A NO 862372A NO 862372 A NO862372 A NO 862372A NO 862372 D0 NO862372 D0 NO 862372D0
Authority
NO
Norway
Prior art keywords
quinolo
derivatives
procedure
preparation
therapeutic active
Prior art date
Application number
NO862372A
Other languages
English (en)
Other versions
NO862372L (no
Inventor
Roy Victor Davies
James Fraser
Kenneth John Nichol
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Plc filed Critical Boots Co Plc
Publication of NO862372D0 publication Critical patent/NO862372D0/no
Publication of NO862372L publication Critical patent/NO862372L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Quinoline Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO862372A 1985-06-15 1986-06-13 Fremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater. NO862372L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858515209A GB8515209D0 (en) 1985-06-15 1985-06-15 Therapeutic agents

Publications (2)

Publication Number Publication Date
NO862372D0 true NO862372D0 (no) 1986-06-13
NO862372L NO862372L (no) 1986-12-16

Family

ID=10580805

Family Applications (1)

Application Number Title Priority Date Filing Date
NO862372A NO862372L (no) 1985-06-15 1986-06-13 Fremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater.

Country Status (19)

Country Link
US (1) US4772614A (no)
EP (1) EP0206616A3 (no)
JP (1) JPS6236361A (no)
KR (1) KR870000302A (no)
CN (1) CN86104611A (no)
AU (1) AU5838286A (no)
DD (1) DD249010A5 (no)
DK (1) DK272386A (no)
ES (1) ES8801211A1 (no)
FI (1) FI862519A (no)
GB (1) GB8515209D0 (no)
GR (1) GR861528B (no)
HU (1) HUT42073A (no)
IL (1) IL79039A0 (no)
JO (1) JO1483B1 (no)
NO (1) NO862372L (no)
PH (1) PH22992A (no)
PT (1) PT82760B (no)
ZA (1) ZA864288B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3576686D1 (de) * 1984-08-15 1990-04-26 Boots Co Ltd Chinolinone, verfahren zu ihrer herstellung und die sie enthaltenden pharmazeutischen praeparate.
GB8627698D0 (en) * 1986-11-20 1986-12-17 Boots Co Plc Therapeutic agents
GB8726950D0 (en) * 1987-11-18 1987-12-23 Boots Co Plc Chemical process
GB8804016D0 (en) * 1988-02-22 1988-03-23 Boots Co Plc Therapeutic agents
DE68917024D1 (de) * 1988-05-24 1994-09-01 Kirin Brewery 4(1H)-Chinolonderivate.
GB8918952D0 (en) * 1989-08-19 1989-10-04 Boots Co Plc Therapeutic agents
US5927566A (en) * 1996-07-11 1999-07-27 Aptargroup, Inc. One-piece dispensing system and method for making same
JP2002522388A (ja) * 1998-08-03 2002-07-23 ビーエーエスエフ コーポレーション 性機能障害の治療のためのピリジノン
US6458804B1 (en) 2001-01-26 2002-10-01 R.T. Alamo Venturesi, Llc Methods for the treatment of central nervous system disorders in certain patient groups
US6451813B1 (en) 2001-01-26 2002-09-17 R. T. Alamo Ventures I, Llc Treatment of gastroparesis in certain patient groups
US6562838B2 (en) * 2001-01-26 2003-05-13 R. T. Alamo Ventures I, L.L.C. Treatment of cardiovascular disease with quinolinone enantiomers
WO2004041264A1 (en) * 2002-11-07 2004-05-21 Astrazeneca Ab 2-oxo-ethanesulfonamide derivates
CN103864680B (zh) * 2012-12-12 2015-09-02 王子厚 具有抗肿瘤活性的氯氧喹衍生物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4913185A (no) * 1972-06-02 1974-02-05
NZ193167A (en) * 1979-03-27 1984-08-24 Boots Co Plc Quinoline derivatives and pharmaceutical compositions
IE51542B1 (en) * 1980-09-26 1987-01-07 Boots Co Ltd Therapeutic agents
PT79031B (en) * 1983-08-20 1986-08-22 Boots Co Plc Therapeutic agents
EP0149519B1 (en) * 1984-01-13 1990-06-27 The Boots Company PLC Use of quinolones for the manufacture of a composition for the treatment of heart failure.
DE3576686D1 (de) * 1984-08-15 1990-04-26 Boots Co Ltd Chinolinone, verfahren zu ihrer herstellung und die sie enthaltenden pharmazeutischen praeparate.

Also Published As

Publication number Publication date
IL79039A0 (en) 1986-09-30
JPS6236361A (ja) 1987-02-17
KR870000302A (ko) 1987-02-17
PT82760A (en) 1986-07-01
PH22992A (en) 1989-02-24
ZA864288B (en) 1987-01-28
ES8801211A1 (es) 1987-12-16
JO1483B1 (en) 1988-03-10
EP0206616A2 (en) 1986-12-30
DD249010A5 (de) 1987-08-26
PT82760B (en) 1988-05-19
NO862372L (no) 1986-12-16
HUT42073A (en) 1987-06-29
DK272386D0 (da) 1986-06-10
ES556027A0 (es) 1987-12-16
FI862519A0 (fi) 1986-06-12
US4772614A (en) 1988-09-20
FI862519A (fi) 1986-12-16
GR861528B (en) 1986-10-10
AU5838286A (en) 1986-12-18
GB8515209D0 (en) 1985-07-17
EP0206616A3 (en) 1988-06-01
DK272386A (da) 1986-12-16
CN86104611A (zh) 1988-01-27

Similar Documents

Publication Publication Date Title
NO864126D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyridon-derivater.
NO163406C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinolinonderivater.
NO871266L (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
NO862477D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-arylimidazol-derivater.
NO883974L (no) Fremgangsmaate for fremstilling av terapeutiske aktive tetrahydro-hydroksypyranon-derivater.
NO894630L (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinuklidin-derivater.
NO870526L (no) Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater.
NO874032L (no) Fremgangsmaate for fremstilling av terapeutisk aktive catecholderivater.
NO862956L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrimidin-derivater.
NO864879L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazolforbindelser.
NO864674D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive cefemforbindelser.
NO862373D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridoner.
NO864130L (no) Fremgangsmaate for fremstilling av terapeutisk aktive karboksamid-derivater.
NO875488L (no) Fremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater.
NO171592C (no) Fremgangsmaate for fremstilling av aktive cinnolin-derivater
NO864131D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive indol-og indazol-ketosulfon-derivater.
NO862372D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater.
NO164897C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive oxazolidinonderivater.
NO861584L (no) Fremgangsmaate til fremstilling av terapeutisk aktive cyklopentyletere.
NO891723L (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
NO865012L (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzazepin-derivater.
NO864101D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilinderivater.
NO162072C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tienopyridinderivater.
NO871907D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive alkenamid-derivater.
NO168473C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenylthiazoloner.